HighTower Advisors, LLC - ADAMIS PHARMACEUTICALS CORP ownership

ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 46 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q3 2022. The put-call ratio across all filers is 0.00 and the average weighting 0.0%.

Quarter-by-quarter ownership
HighTower Advisors, LLC ownership history of ADAMIS PHARMACEUTICALS CORP
ValueSharesWeighting
Q4 2022$13,200
+120.0%
58,190
+311.8%
0.00%
Q3 2022$6,000
-84.6%
14,129
-89.1%
0.00%
Q2 2022$39,000
+2.6%
129,350
+158.1%
0.00%
Q1 2022$38,000
+22.6%
50,115
+25.6%
0.00%
Q4 2021$31,000
-57.5%
39,890
-58.9%
0.00%
Q3 2021$73,000
+192.0%
97,050
+154.1%
0.00%
Q2 2021$25,000
-7.4%
38,200
+213.3%
0.00%
Q1 2019$27,000
-3.6%
12,191
-11.0%
0.00%
Q4 2018$28,000
-36.4%
13,6910.0%0.00%
Q3 2018$44,000
+15.8%
13,691
+15.1%
0.00%
Q2 2018$38,000
-11.6%
11,8960.0%0.00%
Q1 2018$43,0000.0%11,896
+11.2%
0.00%
Q4 2017$43,000
-77.9%
10,696
-66.4%
0.00%
-100.0%
Q1 2016$195,000
+13.4%
31,8000.0%0.00%
-50.0%
Q4 2015$172,000
+39.8%
31,8000.0%0.00%0.0%
Q3 2015$123,000
+108.5%
31,800
+112.0%
0.00%
+100.0%
Q1 2015$59,000
-76.7%
15,000
-63.4%
0.00%
-75.0%
Q4 2014$253,000
-6.6%
41,000
-29.3%
0.00%
-20.0%
Q3 2014$271,000
-14.5%
58,000
-12.1%
0.01%0.0%
Q2 2014$317,00066,0000.01%
Other shareholders
ADAMIS PHARMACEUTICALS CORP shareholders Q3 2022
NameSharesValueWeighting ↓
BARD ASSOCIATES INC 124,300$87,0000.04%
Hayden Royal, LLC 16,000$12,272,0000.01%
Global Strategic Investment Solutions, LLC 23,000$16,0000.01%
Founders Capital Management 8,000$6,0000.01%
Cable Hill Partners, LLC 20,000$14,0000.00%
Jacobi Capital Management LLC 25,000$18,0000.00%
Stonebridge Capital Advisors LLC 22,000$15,0000.00%
B. Riley Wealth Advisors, Inc. 37,520$27,0000.00%
Firestone Capital Management 5,200$4,0000.00%
MGO ONE SEVEN LLC 10,615$7,0000.00%
View complete list of ADAMIS PHARMACEUTICALS CORP shareholders